BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/15/2026 8:12:52 AM | Browse: 1 | Download: 1
 |
Received |
|
2025-09-15 08:20 |
|
Peer-Review Started |
|
2025-09-15 08:20 |
|
First Decision by Editorial Office Director |
|
2025-09-20 01:57 |
|
Return for Revision |
|
2025-09-20 01:57 |
|
Revised |
|
2025-09-22 19:48 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-01 03:10 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-01 10:22 |
|
Articles in Press |
|
2025-12-01 10:22 |
|
Edit the Manuscript by Language Editor |
|
2025-12-06 22:29 |
|
Typeset the Manuscript |
|
2026-01-06 05:47 |
|
Publish the Manuscript Online |
|
2026-01-15 08:12 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Comparison of 6% hydroxyethyl starch 130/0.4 vs 5% albumin in cardiopulmonary bypass for cardiac surgery
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ahmed Alqarni, Abdulwahab Algarni and Rejina Chhetri |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rejina Chhetri, Department of Cardiology, Nepalgunj Medical College, Das Bigha, Kohalpur - 11, Kohal 21900, Nepal. rejinachhetri01@gmail.com |
| Key Words |
Cardiopulmonary bypass; Cardiac surgery; Hydroxyethyl starch; Albumin; Acute kidney injury; Platelet count; Blood loss |
| Core Tip |
This meta-analysis systematically compares 6% hydroxyethyl starch 130/0.4 and 5% human albumin as priming and volume replacement fluids in cardiac surgery with cardiopulmonary bypass. It highlights comparable safety and efficacy profiles between the two colloids in terms of bleeding, transfusion needs, intensive care unit stay, and mortality, while identifying a higher risk of acute kidney injury associated with hydroxyethyl starch. These findings challenge traditional preferences and emphasize the need for individualized fluid choice guided by patient factors and evolving regulatory considerations in perioperative cardiac care. |
| Publish Date |
2026-01-15 08:12 |
| Citation |
Alqarni A, Algarni A, Chhetri R. Comparison of 6% hydroxyethyl starch 130/0.4 vs 5% albumin in cardiopulmonary bypass for cardiac surgery. World J Cardiol 2026; 18(1): 114123 |
| URL |
https://www.wjgnet.com/1949-8462/full/v18/i1/114123.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v18.i1.114123 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
